On July 8, 2021 Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, reported that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, and Linda Rubinstein, Chief Financial Officer, will participate in the following upcoming investor conferences in July (Press release, Apexigen, JUL 8, 2021, View Source [SID1234590989]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William Blair Biotech Focus Conference 2021
Format: Corporate update and one-on-one investor meetings
Presentation Date & Time: Thursday, July 15, 2021, at 11:00 a.m. ET
Presentation Webcast: Click Here

LifeSci Annual Summer Symposium
Format: Corporate update
Presentation Date & Time: Wednesday, July 21, 2021, at 11:30 a.m. ET
Registration: Click Here